---
figid: PMC10937592__gr4
figtitle: SCFAs bind with FFAR2, FFAR3 and GPR109A to improve hepatic steatosis, respectively
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10937592
filename: gr4.jpg
figlink: /pmc/articles/PMC10937592/figure/F4
number: F4
caption: SCFAs bind with FFAR2, FFAR3 and GPR109A to improve hepatic steatosis, respectively.
  (a) SCFAs stimulate FFAR2 to activate M2 macrophages, which upregulate TNF-α expression
  and inhibit liver inflammation. Meanwhile, under the action of SCFAs, FFAR2 can
  decrease FFA content to improve hepatic steatosis by Gi pathway. (b) SCFAs activate
  FFAR3 to down-regulate lipid synthesis genes (Fas and PPARα). (c) SCFAs induce T
  cell differentiation into Treg cells and IL-10-producing T cells via GPR109A signalling,
  which alleviate liver inflammation. SCFAs, short-chain fatty acids; FFAR2, free
  fatty acid receptor 2; TNF-α, tumor necrosis factor-α; FFA, Free fat acid; FFAR3,
  free fatty acid receptor 3; GPR109A, G protein-coupled receptor 109A
papertitle: 'Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects
  for short-chain fatty acids as therapeutic targets'
reftext: Xinyu Li, et al. Heliyon. 2024 Mar 15;10(5).
year: '2024'
doi: 10.1016/j.heliyon.2024.e26991
journal_title: Heliyon
journal_nlm_ta: Heliyon
publisher_name: Elsevier
keywords: Nonalcoholic fatty liver disease | Gut microbiota | Short-chain fatty acids
  | Genetic mechanisms | Epigenetic mechanisms
automl_pathway: 0.8894239
figid_alias: PMC10937592__F4
figtype: Figure
redirect_from: /figures/PMC10937592__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10937592__gr4.html
  '@type': Dataset
  description: SCFAs bind with FFAR2, FFAR3 and GPR109A to improve hepatic steatosis,
    respectively. (a) SCFAs stimulate FFAR2 to activate M2 macrophages, which upregulate
    TNF-α expression and inhibit liver inflammation. Meanwhile, under the action of
    SCFAs, FFAR2 can decrease FFA content to improve hepatic steatosis by Gi pathway.
    (b) SCFAs activate FFAR3 to down-regulate lipid synthesis genes (Fas and PPARα).
    (c) SCFAs induce T cell differentiation into Treg cells and IL-10-producing T
    cells via GPR109A signalling, which alleviate liver inflammation. SCFAs, short-chain
    fatty acids; FFAR2, free fatty acid receptor 2; TNF-α, tumor necrosis factor-α;
    FFA, Free fat acid; FFAR3, free fatty acid receptor 3; GPR109A, G protein-coupled
    receptor 109A
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FFAR2
  - FFAR3
  - HCAR2
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - TNF
  - FAS
  - FASN
  - PPARA
  - LPL
  - SCFAs
  - TNF-a
  - FFA
  - Fas
---
